142 related articles for article (PubMed ID: 23209540)
41. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogues.
Nieman JA; Coleman JE; Wallace DJ; Piers E; Lim LY; Roberge M; Andersen RJ
J Nat Prod; 2003 Feb; 66(2):183-99. PubMed ID: 12608848
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of fluoro analogues of antimitotic phenstatin.
Ghinet A; Tourteau A; Rigo B; Stocker V; Leman M; Farce A; Dubois J; Gautret P
Bioorg Med Chem; 2013 Jun; 21(11):2932-40. PubMed ID: 23618708
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3'-hydroxy-4'-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006).
Macdonough MT; Strecker TE; Hamel E; Hall JJ; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem; 2013 Nov; 21(21):6831-43. PubMed ID: 23993969
[TBL] [Abstract][Full Text] [Related]
45. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
46. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J
Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935
[TBL] [Abstract][Full Text] [Related]
47. Total synthesis of cryptophycin analogues via a scaffold approach.
McCubbin JA; Maddess ML; Lautens M
Org Lett; 2006 Jul; 8(14):2993-6. PubMed ID: 16805535
[TBL] [Abstract][Full Text] [Related]
48. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
Georg GI; Ali SM; Stella VJ; Waugh WN; Himes RH
Bioorg Med Chem Lett; 1998 Aug; 8(15):1959-62. PubMed ID: 9873466
[TBL] [Abstract][Full Text] [Related]
49. 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.
Ruchelman AL; Houghton PJ; Zhou N; Liu A; Liu LF; LaVoie EJ
J Med Chem; 2005 Feb; 48(3):792-804. PubMed ID: 15689163
[TBL] [Abstract][Full Text] [Related]
50. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and biological evaluation of analogues of the marine cyclic depsipeptide obyanamide.
Zhang W; Ding N; Li Y
J Pept Sci; 2011 Jul; 17(7):533-9. PubMed ID: 21495118
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of 15,20-triamide analogue with polar substituent on the phenyl ring of arenastatin A, an extremely potent cytotoxic spongean depsipeptide.
Kotoku N; Kato T; Narumi F; Ohtani E; Kamada S; Aoki S; Okada N; Nakagawa S; Kobayashi M
Bioorg Med Chem; 2006 Nov; 14(22):7446-57. PubMed ID: 16877000
[TBL] [Abstract][Full Text] [Related]
53. Enantioselective synthesis of a 3'-dephenylcryptophycin synthon.
Eggen MJ; Georg GI
Bioorg Med Chem Lett; 1998 Nov; 8(22):3177-80. PubMed ID: 9873698
[TBL] [Abstract][Full Text] [Related]
54. Tracking Fluorine during Aqueous Photolysis and Advanced UV Treatment of Fluorinated Phenols and Pharmaceuticals Using a Combined
Bhat AP; Mundhenke TF; Whiting QT; Peterson AA; Pomerantz WCK; Arnold WA
ACS Environ Au; 2022 May; 2(3):242-252. PubMed ID: 37102144
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and biological evaluation of novel fluorinated docetaxel analogues.
Lu HF; Sun X; Xu L; Lou LG; Lin GQ
Eur J Med Chem; 2009 Feb; 44(2):482-91. PubMed ID: 18524425
[TBL] [Abstract][Full Text] [Related]
56. Analogues of the potent nonpolyglutamatable antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine (PT523) with modifications in the side chain, p-aminobenzoyl moiety, or 9,10-bridge: synthesis and in vitro antitumor activity.
Rosowsky A; Wright JE; Vaidya CM; Forsch RA; Bader H
J Med Chem; 2000 Apr; 43(8):1620-34. PubMed ID: 10780919
[TBL] [Abstract][Full Text] [Related]
57. Binding of the epoxide cryptophycin analog, LY355703 to albumin and its effect on in vitro antiproliferative activity.
Schultz RM; Shih C; Wood PG; Harrison SD; Ehlhardt WJ
Oncol Rep; 1998; 5(5):1089-94. PubMed ID: 9683814
[TBL] [Abstract][Full Text] [Related]
58. A two step synthesis of a key unit B precursor of cryptophycins by asymmetric hydrogenation.
Sammet B; Brax M; Sewald N
Beilstein J Org Chem; 2011 Feb; 7():243-5. PubMed ID: 21448253
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and Biological Evaluation of CF
Han ZZ; Dong T; Ming XX; Kuang F; Zhang CP
ChemMedChem; 2021 Oct; 16(20):3177-3180. PubMed ID: 34268896
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein.
Jain HD; Zhang C; Zhou S; Zhou H; Ma J; Liu X; Liao X; Deveau AM; Dieckhaus CM; Johnson MA; Smith KS; Macdonald TL; Kakeya H; Osada H; Cook JM
Bioorg Med Chem; 2008 Apr; 16(8):4626-51. PubMed ID: 18321710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
